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Abstract The aim of this study was to estimate the
hospitalization incidence and the total number of hos-
pital days related to all fractures and osteoporotic
fractures in the year 2000 in Switzerland and to com-
pare these with data from other frequent disorders in
men and women. The oﬃcial administrative and med-
ical statistics database of the Swiss Federal Oﬃce of
Statistics (SFOS) from the year 2000 was used. It cov-
ered 81.2% of all registered patient admissions and was
considered to be representative of the entire population.
We included the ICD-10 codes of 84 diagnoses that
were compatible with an underlying osteoporosis and
applied the best matching age-speciﬁc osteoporosis
attribution rates published for the ICD-9 diagnosis
codes to the individual ICD-10 codes. To preserve
comparability with previously published data from
1992, we grouped the data related to the ICD-10 frac-
ture codes into seven diagnosis pools (fractures of the
axial skeleton, fractures of the proximal upper limbs,
fractures of the distal upper limbs, fractures of the
proximal lower limbs, fractures of the distal lower
limbs, multiple fractures, and osteoporosis) and ana-
lyzed them separately for women and men by age
group. Incidences of hospitalization due to fractures
were calculated, and the direct medical costs related to
hospitalization were estimated. In addition, we com-
pared the results with those from chronic pulmonary
obstructive disease (COPD), stroke, acute myocardial
infarction, heart failure, diabetes and breast carcinoma
from the same database. In Switzerland during 2000,
62,535 hospitalizations for fractures (35,586 women and
26,949 men) were registered. Fifty-one percent of all
fractures in women and 24% in men were considered as
osteoporotic. The overall incidences of hospitalization
due to fractures were 969 and 768 per 100,000 in wo-
men and men, respectively. The hospitalization inci-
dences for fractures of the proximal lower limbs and the
axial skeleton increased exponentially after the age of
65 years. The direct medical cost of hospitalization of
patients with osteoporosis and/or related fractures was
357 million CHF. Hip fractures accounted for approx-
imately half of these costs in women and men. Among
other common diseases in women and men, osteopo-
rosis ranked number 1 in women and number 2 (behind
COPD) in men. When compared with data from 1992,
the average length of stay had shortened by 8.4 days for
women and 4.7 days for men, leading to a decrease of
almost 40% in direct medical costs related to acute
hospitalizations. This apparent decrease in cost might
result from a shift into the ambulatory cost segment,
for which the assessment and management tools need to
be developed. We conclude that, in 2000, osteoporosis
continued to be a heavy burden on the Swiss healthcare
system. Lack of awareness of the disease and its con-
sequences prevents widespread use of drugs with anti-
fracture eﬃcacy. This limits their potential to reduce
costs.
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Introduction
Osteoporosis is a skeletal disease characterized by low
bone mass and a deterioration in bone micro-architec-
ture that results in enhanced bone fragility and increased
susceptibility to fractures [1]. The commonly reported
osteoporotic fractures occur in the forearm, vertebra
and hip [2]. However, osteoporosis is a systemic disease
of the skeleton, and osteoporotic fractures may also
occur at the proximal humerus, ribs, tibia, pelvis, knee,
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and ankle [1, 3, 4, 5, 6]. In osteoporotic patients virtually
any bone may be fractured by so-called inadequate or
low-energy trauma.
In 1992 we estimated the annual direct medical costs
of hospitalization due to osteoporotic fractures in
Switzerland that had been recorded by the medical sta-
tistics department of VESKA (Vereinigung Schweizeri-
scher Krankenhaeuser, the Swiss Hospital Association),
and compared these costs with those due to other
common diseases in men and women. We concluded
that osteoporotic fractures in women consumed more
healthcare resources than chronic pulmonary obstruc-
tive disease (COPD), stroke, breast carcinoma and
myocardial infarction (MI). In men, osteoporosis
ranked fourth behind COPD, MI and stroke [7].
The aim of our study was to update our knowledge of
the socio-economic burden of osteoporosis in Switzer-
land by analyzing the hospitalization incidence and the
total number of hospitalization days related to osteo-
porotic fractures, and fractures in general, and to com-
pare the total hospitalization days due to osteoporosis
with those caused by other common disorders in men
and women.
Materials and methods
Source of hospital statistics
The administrative and medical statistics database of the
Swiss Federal Oﬃce of Statistics (SFOS) from 2000 was
used. Since 1998 all Swiss acute hospitals, as well as
rehabilitation centers and specialized clinics, have been
obliged to supply data to the SFOS. There were 376 such
institutions, and administrative statistics were available
from 372 of them (four had closed during 2000). These
administrative statistics consolidate the data relating to
ﬁnance, human resources, numbers of beds and patient
admissions. Medical statistics were available from 343
hospitals (91.2%), corresponding to 81.2% of all regis-
tered patient admissions. We used those medical statis-
tics to determine the number of hospitalized fractures
and to calculate the mean length of stay (LOS) by
fracture type, age group and gender. All data were
extrapolated to 100% to become representative for
Switzerland as a whole.
Deﬁnition of fracture and osteoporotic fracture
In the medical statistics database the diagnoses were
coded as main or secondary. To calculate the numbers of
diagnoses related to fractures and/or osteoporosis, we
retained both main and secondary diagnoses. All diag-
noses were coded according to the ICD-10 classiﬁcation.
Eighty-four ICD-10 codes were relevant to our analysis,
and they were assigned to four categories:
– Category 1: osteoporosis coded as such. There were
21 relevant ICD-10 codes; osteoporosis without
pathologic fracture: M81.0 (postmenopausal osteo-
porosis), M81.1 (osteoporosis after ovariectomy),
M81.2 (immobilization osteoporosis), M81.3 (oste-
oporosis consecutive to post-surgical malabsorp-
tion), M81.4 (drug-induced osteoporosis), M81.5
(idiopathic osteoporosis), M81.6 (regional osteopo-
rosis [Lequesne]), M81.8 (other osteoporosis),
M81.9 (osteoporosis, no further mention), M82.0
(osteoporosis with plasmacytoma), M82.1 (osteo-
porosis with endocrine diseases), M82.8 (osteopo-
rosis with other classiﬁed diseases); osteoporosis with
pathologic fracture: M80.0 (postmenopausal osteo-
porosis with pathologic fracture), M80.1 (osteopo-
rosis with pathologic fracture after ovariectomy),
M80.2 (immobilization osteoporosis with pathologic
fracture), M80.3 (osteoporosis consecutive to post-
surgical malabsorption with pathologic fracture),
M80.4 (drug-induced osteoporosis with pathologic
fracture), M80.5 (idiopathic osteoporosis with
pathologic fracture), M80.8 (other osteoporosis with
pathologic fracture), M80.9 (osteoporosis, no fur-
ther mention with pathologic fracture), M84.4
(pathologic fracture, not classiﬁed elsewhere).
– Category 2: osteoporosis-related clinical entities not
deﬁned as osteoporosis, including back pain and
kyphosis. Comprises six relevant ICD-10 codes
(Table 1).
– Category 3: fractures possibly due to osteoporosis,
typically those caused by low-energy trauma.
Comprises 28 eligible ICD-10 codes (Table 2).
– Category 4: fractures unlikely to be due to osteo-
porosis, typically those caused by high-energy
trauma. Comprises 29 relevant ICD-10 codes: S42.0
(fracture clavicula), S42.4 (fracture humerus distal),
S42.7 (multiple fractures clavicula), S42.8 (other
Table 1 Osteoporosis attribution rates by age group for osteoporosis-related clinical entities
Main diagnosis ICD-10 description Attribution rates by age group
ICD-10 0–44 45–54 55–64 65–74 75–84 85+
M54.5 Back pain 0.00 0.25 0.38 0.50 0.50 0.50
M54.6 Pain in thoracic spine 0.00 0.40 0.49 0.58 0.58 0.58
M54.8 Other back pain 0.00 0.25 0.38 0.50 0.50 0.50
M54.9 Back pain, without further mention 0.00 0.25 0.38 0.50 0.50 0.50
M40.1 Other secondary kyphosis 0.00 0.85 0.85 0.85 0.85 0.85
M40.2 Other secondary kyphosis, with no
further mention
0.00 0.85 0.85 0.85 0.85 0.85
S9
fractures of the shoulder, upper arm), S42.9 (frac-
ture of the shoulder, no further mention), S52.0
(fracture ulna proximal), S52.1 (fracture radius
proximal), S52.3 (fracture of the radius shaft), S52.4
(combined fracture of the radius/ulna), S52.7 (mul-
tiple fractures of the forearm), S52.8 (fracture of the
forearm, other), S52.9 (fracture of the forearm, no
further mention), S62 (fracture of the hand and
wrist), S72.3 (fracture of the femur shaft), S72.7
(multiple fractures femur), S82.0 (fracture patella),
S82.7 (multiple fractures of the lower leg), S82.8
(fractures of the lower leg, other), S82.9 (fracture of
the lower leg, no further mention), S92 (fracture of
the foot, excluding ankle), T02.1 (fractures involving
thoracic and lumbar spine and pelvis), T02.2 (mul-
tiple fractures of the upper limb), T02.3 (multiple
fractures of the lower limb), T02.4 (multiple frac-
tures of both upper limbs), T02.5 (multiple fractures
of both lower limbs), T02.6 (multiple fractures of the
lower and upper limbs), T02.7 (fractures involving
thoracic and lumbar spine and pelvis and limbs),
T02.8 (other combined fractures), T02.9 (multiple
fractures, no further mention).
Osteoporosis attribution rates
The percentage of hospitalization cases related to oste-
oporosis was estimated by applying the best matching
age-speciﬁc attribution rates published for the ICD-9
diagnosis codes [7, 8, 9] to the individual ICD-10 codes.
To preserve comparability with our previous publica-
tion, we used the conservative attribution rates pub-
lished by Phillips et al. [8], although a more recent and
detailed publication from Melton et al. examines age-
speciﬁc and gender-speciﬁc attribution rates and indi-
cates that osteoporosis might be the underlying cause of
fracture more frequently than initially suspected [9]. In
category 1 all recorded cases were counted as being due
to osteoporosis (attribution rate 100%). In category 2
all cases were weighted according to the age-speciﬁc
attribution rates (Table 1). In category 3 (main diag-
nosis fracture), cases with a secondary diagnosis of
osteoporosis were attributed to osteoporosis (attribution
rate 100%) and cases with a secondary diagnosis other
than osteoporosis were weighted according to the age-
speciﬁc attribution rates (Table 2). In category 4 (main
diagnosis fracture), cases with a secondary diagnosis of
osteoporosis were attributed to osteoporosis (attribution
rate 100%), while cases with a secondary diagnosis other
than osteoporosis were considered as not being due to
osteoporosis (attribution rate 0%).
Data pooling for analysis
In a second step, to preserve comparability with previ-
ously published data [7], we grouped the ICD-10 frac-
Table 2 Osteoporosis attribution rates by age group for fractures possibly due to osteoporosis
Main diagnosis ICD-10 description Attribution rates by age group
ICD-10 0–44 45–54 55–64 65–74 75–84 85+
M48.4 Vertebral fatigue fracture 0.00 0.82 0.85 0.88 0.89 0.89
M48.5 Vertebral compression fracture,
not classiﬁed elsewhere
0.00 0.72 0.74 0.75 0.75 0.75
M84.3 Stress fracture, not classiﬁed elsewhere 0.00 0.82 0.85 0.88 0.89 0.89
S22.0 Fracture of the thoracic spine 0.00 0.72 0.74 0.75 0.75 0.75
S22.1 Multiple fractures of the thoracic spine 0.00 0.72 0.74 0.75 0.75 0.75
S22.3 Rib fracture 0.00 0.72 0.74 0.75 0.75 0.75
S32.0 Fracture of the lumbar spine 0.00 0.60 0.68 0.75 0.90 0.90
S32.1 Fracture of the sacrum 0.00 0.60 0.68 0.75 0.90 0.90
S32.5 Fracture of the pubis 0.00 0.60 0.68 0.75 0.90 0.90
S32.7 Multiple fractures of the lumbar spine 0.00 0.60 0.68 0.75 0.90 0.90
S32.8 Other fractures of the lumbar spine 0.00 0.60 0.68 0.75 0.90 0.90
S42.2 Fracture of the proximal humerus 0.00 0.40 0.45 0.50 0.70 0.70
S42.3 Fracture of the humerus shaft 0.00 0.40 0.45 0.50 0.70 0.70
S52.2 Fracture of the ulna shaft 0.00 0.70 0.74 0.78 0.84 0.84
S52.5 Fracture of the distal radius 0.00 0.70 0.74 0.78 0.84 0.84
S52.6 Combined fracture of the distal radius/ulna 0.00 0.70 0.74 0.78 0.84 0.84
S72.0 Fracture of the femoral neck 0.00 0.51 0.61 0.71 0.91 0.91
S72.1 Pertrochanteric fracture 0.00 0.51 0.61 0.71 0.91 0.91
S72.2 Subtrochanteric fracture 0.00 0.51 0.61 0.71 0.91 0.91
S72.4 Fracture of the femur, distal 0.00 0.51 0.61 0.71 0.91 0.91
S72.8 Fracture of the femur, other 0.00 0.51 0.61 0.71 0.91 0.91
S72.9 Fracture of the femur, no further mention 0.00 0.51 0.61 0.71 0.91 0.91
S82.1 Fracture of the tibia, proximal 0.00 0.40 0.45 0.50 0.60 0.60
S82.2 Fracture of the tibia shaft 0.00 0.40 0.45 0.50 0.60 0.60
S82.3 Fracture of the tibia, distal 0.00 0.40 0.45 0.50 0.60 0.60
S82.4 Fracture of the ﬁbula 0.00 0.40 0.45 0.50 0.60 0.60
S82.5 Fracture of the malleolar int 0.00 0.40 0.45 0.50 0.60 0.60
S82.6 Fracture of the malleolar ext 0.00 0.40 0.45 0.50 0.60 0.60
S10
ture codes into seven diagnosis pools and tabulated them
separately for women (Table 3) and men (Table 4) as
follows: (1) fractures of the axial skeleton, (2) fractures
of the proximal upper limbs, (3) fractures of the distal
upper limbs, (4) fractures of the proximal lower limbs,
(5) fractures of the distal lower limbs, (6) multiple
fractures and (7) osteoporosis.
Calculation of the incidences of hospitalization
due to fractures
The structure of the Swiss population in 2000 was used,
divided into six age groups by gender (0–44, 45–54, 55–
64, 65–74, 75–84 and ‡85 years), as published by the
Swiss Federal Oﬃce of Statistics.
Estimation of the direct medical costs related
to hospitalization
The Administrative Statistics showed the operational
cost for general hospitals (including university hospitals)
as being CHF 1,009 per hospital day and CHF 703 as
the weighted average cost per day in special or rehabil-
itation clinics. It was assumed that within a given age
group the mean length of stay was the same whether
osteoporosis was the underlying cause or not. We mul-
tiplied the number of hospital days by the number of
cases and by the cost per day to obtain an estimation of
the total hospitalization costs related to osteoporosis
and its complications.
Selected diseases used as comparators
Hospitalization days caused by COPD (ICD-10 codes
J40–J47), stroke (I64, I66), acute myocardial infarction
(I21, I22), heart failure (I50), diabetes (E10–E14) and
breast carcinoma (C50) were assessed by the same
methodology as described above. Those diseases repre-
sent well-established nosologic entities and are usually
coded as the main diagnosis if they are the main reason
for hospitalization. In contrast to osteoporosis, where
fractures can be attributed to the underlying disease with
a given probability, no such attribution rates exist for
the complications of the selected comparator diseases.
Therefore, we focused on the main diagnosis only.
Results
Hospitalizations due to fractures and osteoporotic
fractures
In Switzerland 62,535 hospitalizations for fractures
(35,586 women and 26,949 men) occurred during 2000
(Tables 3 and 4). Overall, 51% of those hospitalizations
in women and 24% in men were considered to be due to
osteoporosis, with large diﬀerences according to fracture
site and gender. Thus, 80% of the hospitalizations for
fractures of the proximal lower limbs and 59.3% of
those for fractures of the axial skeleton were considered
as osteoporotic in women (56.5% and 37.5%, respec-
tively, in men), whereas 41% of the hospitalizations for
distal upper limb fractures and 20% of those for distal
lower limb fractures were considered as osteoporotic in
women (8.9% and 13.1%, respectively, in men). In wo-
men, osteoporosis coded as such (ICD-10 M81 and
M82) accounted for 3.5% (compared to 1.6% in men) of
the total hospitalized cases attributable to osteoporosis
based on the attribution rates.
Incidences of hospitalizations due to fractures
The incidences of hospitalization due to fractures were
969 and 768 per 100,000 in women (Table 3) and men
(Table 4), respectively. Pooled incidences by fracture site
and age group are shown for women and men in Figs. 1
and 2, respectively. The incidence of hospitalization for
fractures of the proximal lower limbs and the axial
skeleton sharply increased after the age of 65 years in
both genders. The incidence of fractures of the proximal
lower limbs was higher in men than in women up to the
age of 54 years, and similar at 45–54 years (108/100,000
and 111/100,000, respectively) and rose exponentially
thereafter in both genders. At age 85+ the incidence was
3,874/100,000 in women and 1,940/100,000 in men. The
incidence of hospitalization for fractures of the axial
skeleton also increased strongly with age, from 68/
100,000 (0–44 years) to 1,690/100,000 (85+ years) in
women, and from 97/100,000 to 784/100,000 in men in
the same age groups.
Direct medical costs related to hospitalization
The total estimated cost due to osteoporosis and related
fractures in Switzerland in 2000 was 357 million CHF.
In women, a total of 35,586 hospitalizations,
amounting to 503,319 hospital days, were estimated to
be due to fractures in 2000. The mean length of stay was
14.1 days. The total hospital costs were approximately
473 million CHF, corresponding to a mean cost per case
of 13,312 CHF. In all, 18,037 hospitalizations have been
estimated to be due to osteoporotic fractures and ac-
counted for a total of 286,397 hospital days, with a mean
length of stay of 15.9 days. The total hospital cost was
estimated at 263.6 million CHF, corresponding to a
mean cost per case of 14,616 CHF. The hip fracture
group had the largest number of cases and the longest
length of stay (19.1 days, on average) and accounted for
more than 50% of the estimated total hospitalization
costs for osteoporotic fractures. Fractures of the axial
skeleton accounted for 30% of these costs (Table 3).
In men, the number of hospitalizations due to frac-
tures in general was 26’949 in 2000, with a mean length
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of stay of 10.1 days, i.e., 4.0 days fewer or 28% less than
in women. These cases accounted for 272,625 hospital
days, i.e., almost 50% less than in women. The cost of
hospitalizations was estimated at 259.2 million CHF,
corresponding to a mean cost per case of 9,620 CHF.
Twenty-four percent of all hospitalizations for fractures
were considered as related to osteoporosis, with 87,100
hospital days and 13.5 days average length of stay
(LOS). The estimated cost of hospitalization due to
osteoporotic fractures was 82 million CHF, with a mean
cost per case of 12,674 CHF. As in women, the main
cost drivers were hip fractures. They were more frequent
and produced the longest LOS (17.9 days), accounting
for 47% of the estimated total hospitalization costs for
osteoporotic fractures. Fractures of the axial skeleton
accounted for 33% of these costs (Table 4).
Comparison with other frequent diseases
In women the age-independent incidence of hospital-
ization for osteoporosis or its complications was twice as
high as that for breast cancer and pooled cardiovascular
diseases (heart failure and myocardial infarction and
stroke), almost three-times as high as that for COPD
and six-times higher than that for diabetes (Fig. 3). The
mean LOS for osteoporosis was similar to that of all the
other diseases included in the analysis, with the excep-
tion of stroke (twice as long) and breast cancer (50%
shorter) (Fig. 4). Osteoporosis accounted for 1.5-times
more hospital days than pooled cardiovascular diseases,
two-to-three-times more than COPD or breast cancer
and six-times more than diabetes (Fig. 5).
In men the disease with the highest hospitalization
incidence and the highest number of hospital days was
COPD. The overall incidence of hospitalizations for
osteoporosis was identical to the incidence of hospital-
izations for myocardial infarction, with a longer mean
length of stay and almost 50% more hospital days
(Figs. 6, 7 and 8).
Discussion
In a previous study [7], which used similar methods to
analyze the 1992 statistics database of the VESKA
Fig. 2 Incidences of hospitalization due to fractures in Swiss men
in year 2000, by age group
Fig. 1 Incidences of hospitalization due to fractures in Swiss
women in year 2000, by age group
Fig. 3 Incidences of hospitalization for osteoporosis and other
frequent diseases in Swiss women in year 2000
Fig. 4 Mean length of stay for osteoporosis and other frequent
diseases in Swiss women in year 2000
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(Vereinigung Schweizer Krankenha¨user, Federation of
Swiss Hospitals), we assessed the incidence rate of
fractures and estimated the direct medical costs linked to
hospitalizations for osteoporosis and its complications.
The 1992 data showed a total of 63,170 hospitaliza-
tions for fractures (53% in women) and the annual
incidences of hospitalizations for fractures were 950 per
100,000 and 877 per 100,000 in women and men,
respectively. In 2000 these values were very similar:
62,535 hospitalizations for fractures, 57% in women,
and incidences of 969 per 100,000 and 768 per 100,000 in
women and men, respectively. In 1992 the total number
of hospitalized osteoporotic fractures was 18,380 in
women (vs 18,037 in 2000) and 7,619 in men (vs 6,470 in
2000). Between 1992 and 2000 the average length of stay
shortened considerably, from 24.3 days to 15.9 days
()8.4 days) in the case of women and from 18.2 to 13.5
days ()4.7 days) in the case of men. This led to a de-
crease of almost 40% in direct medical costs related to
acute hospitalizations for osteoporosis.
As compared to 1992, the number of osteoporotic
fractures of the proximal lower limbs (mainly hip frac-
tures) increased by almost 10% in women and 21% in
men. In women the number of hospitalizations due to
fractures of the axial skeleton increased by 25%. For all
other fracture sites the number of hospitalizations de-
creased by up to 35% (Table 5). The lengths of stay
decreased markedly for all fracture types, the largest
change being seen for hip fractures (around 50%) and
the least change for fractures of the axial skeleton
(around 25%), (Table 6). In women in 1992 osteopo-
rosis was the leading disease, followed by COPD, stroke,
breast cancer and myocardial infarction. This ranking,
and the respective orders of magnitude, remained similar
in 2000. In men in 1992 COPD was the leading cause of
hospitalization, followed by myocardial infarction,
stroke and osteoporosis. In 2000, in men, osteoporosis
progressed from rank 4 to rank 2, ahead of stroke and
myocardial infarction.
There are several possible explanations for these
observations. The Swiss statistical data collection system
has recently changed: in 1992 the VESKA statistics were
derived from a representative sample of 43% of the
Swiss hospitals, based on voluntary membership, which
we extrapolated to 100%. In 2000, membership of the
Fig. 5 Hospital days for osteoporosis and other frequent diseases
in Swiss women in year 2000
Fig. 6 Incidences of hospitalization for osteoporosis and other
frequent diseases in Swiss men in year 2000
Fig. 7 Mean length of stay for osteoporosis and other frequent
diseases in Swiss men in year 2000
Fig. 8 Hospital days for osteoporosis and other frequent diseases
in Swiss men in year 2000
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SFOS was mandatory, and the data shown here were
extrapolated from a statistics database representing
81.2% of all hospital admissions. The diﬀerences in
source data and in the extrapolated sample size might
have introduced some variance. However, as the 1992
VESKA data were a representative sample for all Swiss
hospitals, and as a greater percentage of hospitals re-
ported data in 2000, the data shown here can be con-
sidered a realistic scenario of the number of fractures
and hospitalizations in Switzerland in both years. The
ICD coding system was changed from ICD-9 in 1992 to
the more detailed ICD-10 in 2000. However, the ICD-10
contains codes similar to those in ICD-9, and the data
pooling was done on the basis of diagnoses compatible
with the ICD-9 data classiﬁcation of 1992. In addition,
the incidence of hip fractures, which almost always cause
hospitalization, increased between 1992 and 2000, which
is in line with long-term projections for several coun-
tries: an increase of 38% in hip fracture incidence be-
tween 1983 and 2010 was projected for Finland [10] and
45% between 1986 and 2020 in the USA [11]. Some
scenarios even show an increase in the age-speciﬁc
fracture risk, i.e., an increase in the osteoporosis attri-
bution rate for hip fractures [12, 13]. This has led to a
prediction of a 150% increase in hip fracture rate in the
UK between 1985 and 2016 [14]. For Switzerland, based
on the population ageing scenarios predicted by the
SFOS, and assuming that the osteoporosis attribution
rate by age group would remain constant, we estimated
that an increase in the annual incidence of hip fracture
cases, by 55% between 1992 and 2020, could be realis-
tically expected [15].
The large decrease in the mean length of stay ob-
served for all fractures may have several explanations.
Cost containment measures have aﬀected the Swiss
healthcare system increasingly over the past 10 years,
leading to cost savings at the hospital level. These sav-
ings have been brought about by a shift from hospital-
ization to ambulatory treatment and by earlier hospital
discharge as a result of improved orthopedic surgical
techniques and the shift to ambulatory post-surgery
follow-up. A similar decrease in length of stay has been
observed with all the other common diseases used as
comparators. In women the average LOS for breast
cancer hospitalizations was reduced from 25.7 days in
1992 to 10.5 days in 2000. A similar reduction was ob-
served for heart failure (from 27.1 to 16.8 days), diabetes
(from 25.2 to 15.9 days), myocardial infarction (from
16.7 to 13.5 days), stroke (from 39.9 to 33.1 days) and
COPD (from 20.1 to 17.8 days). In men the average LOS
was reduced for all the diseases, with the exception of
stroke, used as comparators (myocardial infarction de-
creased from 14.1 to 9.3 days, heart failure from 18.1 to
14.8 days, diabetes from 19.5 to 17.2 days, COPD from
17.7 to 16.7 days; stroke increased from 30.0 to 33.5
days).
It is, therefore, likely that a major part of the direct
medical costs of osteoporosis have moved from the well-
Table 5 Number of
hospitalizations for
osteoporotic fractures, year
2000 compared to 1992
Fracture Hospitalizations
1992
Hospitalizations
2000
Diﬀerence
2000 vs 1992
Women
Proximal lower limbs 6,690 7,325 +9.5%
Distal upper limbs 3,449 2,398 )30.5%
Proximal upper limbs 1,885 1,616 )14.3%
Axial skeleton 4,092 5,107 +24.8%
Distal lower limbs 2,264 1,584 )30.0%
Men
Proximal lower limbs 1,876 2,267 +20.8%
Distal upper limbs 989 517 )47.7%
Proximal upper limbs 708 461 )34.9%
Axial skeleton 2,669 2,089 )21.7%
Distal lower limbs 1,377 1,136 )17.5%
Table 6 Mean length of
hospital stay for osteoporotic
fractures, 2000 compared to
1992
Fracture Length of stay 1992
(days)
Length of stay 2000
(days)
Diﬀerence 2000 vs 1992
Women
Proximal lower limbs 30.8 19.1 )38.0%
Distal upper limbs 11.0 7.0 )36.4%
Proximal upper limbs 30.5 14.4 )52.8%
Axial skeleton 24.5 17.0 )30.6%
Distal lower limbs 19.6 12.0 )38.8%
Men
Proximal lower limbs 24.5 17.9 )26.9%
Distal upper limbs 9.9 4.5 )54.6%
Proximal upper limbs 18.8 10.3 )45.2%
Axial skeleton 17.4 14.1 )19.0%
Distal lower limbs 16.8 8.9 )47.0%
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measurable hospital segment to the ambulatory seg-
ment, for which we do not yet have the assessment and
measurement tools in Switzerland.
Since 1996, drugs with a proven eﬀect on the indi-
vidual fracture risk at all clinically relevant sites, such as
the bisphosphonates alendronate and risedronate, have
been available to Swiss physicians. Although these drugs
prevent hip fractures (signiﬁcant reduction of fracture
risk up to 50% in well-designed fracture endpoint trials,
with a measurable between-groups diﬀerence after 36
months [16, 17, 18, 19]), and although the eﬃcacy of
vitamin D substitution and nutritional measures in
institutionalized elderly people is well documented [20,
21, 22], there has been an increase in hospitalizations for
hip fractures over the past 8 years. Projections from
bisphosphonate sales data (IHA/IMS Health, Hergiswil,
2003) for 2000 suggest that fewer than 10% of Swiss
women with osteoporosis were being treated with these
drugs. The year 2000 fracture and hospitalization data
might, therefore, fail to detect a treatment eﬀect on
fracture risk. According to the same source, the avail-
ability of the new once-weekly formulations would
broaden the use of these drugs to approximately 20% of
all women with osteoporosis by the end of 2003, making
it more likely that we will observe a population eﬀect in
the future. However, the awareness of osteoporosis re-
mains low in Switzerland. In the present analysis, and in
the 9,126 reported cases of femoral fracture, only 346
(5.4%) mentioned osteoporosis as a secondary diagnosis
in women. This value drops to 1.9% in men.
Osteoporosis and its complications were the leading
drivers of direct medical costs related to hospitalization
in women in 2000 in Switzerland and were comparable,
as cost drivers, to myocardial infarction in men. Al-
though progress has been made in shortening acute
hospitalization stays and ambulatory treatment of frac-
tures, the costs related to osteoporosis have been shifted
into the ambulatory cost segment, for which the assess-
ment and management tools remain underdeveloped.
Awareness of the consequences of the disease remains
low. This prevents the widespread use of drugs that de-
crease fracture risk in osteoporotic patients and, thereby,
limits their potential contribution to cost containment.
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